---
title: "Publications"
permalink: /publications/
author_profile: true
---

For a complete and up-to-date list visit **PubMed**:  
[https://pubmed.ncbi.nlm.nih.gov/?term=Avgeris+M&sort=date](https://pubmed.ncbi.nlm.nih.gov/?term=Avgeris+M&sort=date)

## Journal Articles

**KMT2C inactivation leads to PTEN downregulation and tolerance to DNA damage during cell cycle progression**  
Rampias T, Goutas A, Karagiannis D, Kanaki Z, Makri A, Hoxhallari L, Koukouzeli FE, Paraskevopoulou V, Tsouraki D, Paschalidis N, **Avgeris M**, Scorilas A, Klinakis A  
**NPJ Precis Oncol.** 2025;9(1):336.  
PubMed: [41152370](https://pubmed.ncbi.nlm.nih.gov/41152370/) · DOI: [10.1038/s41698-025-01101-6](https://doi.org/10.1038/s41698-025-01101-6)

---

**Loss of METTL3 m6A methyltransferase results in short-term progression and poor treatment outcome of bladder cancer patients**  
Pilala KM, Koroneou S, Papadimitriou MA, Panoutsopoulou K, Soureas K, Giagkos GC, Levis P, Linardoutsos D, Stravodimos K, **Avgeris M**, Scorilas A  
**Int J Cancer.** 2026;158(3):763–774.  
PubMed: [40923330](https://pubmed.ncbi.nlm.nih.gov/40923330/) · DOI: [10.1002/ijc.70147](https://doi.org/10.1002/ijc.70147)

---

**NEAT1 lncRNA overexpression results in short-term progression and poor treatment outcome in childhood B-ALL**  
Xagorari M, Marmarinos A, Doganis D, Nikita M, Magkou E, Sfetsiori AE, Baka M, Kossiva L, Pasparaki S, Soldatou A, Tsolia M, Scorilas A, Gourgiotis D, **Avgeris M**  
**Br J Haematol.** 2025;207(6):2475–2485.  
PubMed: [40888247](https://pubmed.ncbi.nlm.nih.gov/40888247/) · DOI: [10.1111/bjh.70127](https://doi.org/10.1111/bjh.70127)

---

**Long-term effects of SARS-CoV-2 infection on children’s vasculature**  
Karaviti D, Charakida M, Dimopoulou D, Marmarinos A, Papadaki M, Maritsi D, Spyridis N, **Avgeris M**, Gourgiotis D, Tsolia M  
**Pediatr Infect Dis J.** 2025;44(8):792–797.  
PubMed: [40294329](https://pubmed.ncbi.nlm.nih.gov/40294329/) · DOI: [10.1097/INF.0000000000004786](https://doi.org/10.1097/INF.0000000000004786)

---

**Lifestyle and biochemical parameters that may hamper immune responses in pediatric patients after immunization with the BNT162b2 mRNA COVID-19 vaccine**  
Damianaki A, Marmarinos A, **Avgeris M**, Gourgiotis D, Vlachopapadopoulou EA, Charakida M, Tsolia M, Kossiva L  
**Diseases.** 2025;13(3):78.  
PubMed: [40136618](https://pubmed.ncbi.nlm.nih.gov/40136618/) · DOI: [10.3390/diseases13030078](https://doi.org/10.3390/diseases13030078)

---

**Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome**  
Soureas K, Malandrakis P, Papadimitriou MA, Minopoulos C, Ntanasis-Stathopoulos I, Liacos CI, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Scorilas A, **Avgeris M**, Terpos E  
**Blood Cancer J.** 2025;15(1):41.  
PubMed: [40089465](https://pubmed.ncbi.nlm.nih.gov/40089465/) · DOI: [10.1038/s41408-025-01248-2](https://doi.org/10.1038/s41408-025-01248-2)

---

**Identification of Oncogene-Induced Senescence-Associated MicroRNAs**  
Foutadakis S, Soureas K, Roupakia E, Besta S, **Avgeris M**, Kolettas E  
**Methods Mol Biol.** 2025;2906:189–213.  
PubMed: [40082357](https://pubmed.ncbi.nlm.nih.gov/40082357/) · DOI: [10.1007/978-1-0716-4426-3_11](https://doi.org/10.1007/978-1-0716-4426-3_11)

---

**Exploring the methyl-verse: Dynamic interplay of epigenome and m6A epitranscriptome**    
Pilala KM, Panoutsopoulou K, Papadimitriou MA, Soureas K, Scorilas A, **Avgeris M**  
**Mol Ther.** 2025;33(2):447–464.  
PubMed: [39659016](https://pubmed.ncbi.nlm.nih.gov/39659016/) · DOI: [10.1016/j.ymthe.2024.12.003](https://doi.org/10.1016/j.ymthe.2024.12.003)

---

**Seroprevalence of diphtheria, tetanus and pertussis antibodies and Tdap vaccination in pregnant women in Greece – A cross-sectional study**  
Papailiou S, Soldatou A, Marmarinos A, **Avgeris M**, Papathoma E, Sindos M, Georgantzi S, Rodolakis A, Iacovidou N, Gourgiotis D, Tsolia M  
**Vaccine.** 2024;42(26):126435.  
PubMed: [39437646](https://pubmed.ncbi.nlm.nih.gov/39437646/) · DOI: [10.1016/j.vaccine.2024.126435](https://doi.org/10.1016/j.vaccine.2024.126435)

---

**CDKN2A copy number alteration in bladder cancer: Integrative analysis in patient-derived xenografts and cancer patients**  
Papadimitriou MA, Pilala KM, Panoutsopoulou K, Levis P, Kotronopoulos G, Kanaki Z, Loules G, Zamanakou M, Linardoutsos D, Sideris DC, Stravodimos K, Klinakis A, Scorilas A, **Avgeris M**  
**Mol Ther Oncol.** 2024;32(2):200818.  
PubMed: [38966038](https://pubmed.ncbi.nlm.nih.gov/38966038/) · DOI: [10.1016/j.omton.2024.200818](https://doi.org/10.1016/j.omton.2024.200818)

---

**MIR145 core promoter methylation in pretreatment cell-free DNA: A liquid biopsy tool for muscle-invasive bladder cancer treatment outcome**  
Pilala KM, Kotronopoulos G, Levis P, Giagkos GC, Stravodimos K, Vassilacopoulou D, Scorilas A, **Avgeris M**  
**JCO Precis Oncol.** 2024;8:e2300414.  
PubMed: [38579191](https://pubmed.ncbi.nlm.nih.gov/38579191/) · DOI: [10.1200/PO.23.00414](https://doi.org/10.1200/PO.23.00414)

---

**Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRFHisGTG results in patients' poor treatment outcome**  
Soureas K, Papadimitriou MA, Malandrakis P, Papanota AM, Adamopoulos PG, Ntanasis-Stathopoulos I, Liacos CI, Gavriatopoulou M, Sideris DC, Kastritis E, Dimopoulos MA, Scorilas A, Terpos E, **Avgeris M**  
**Br J Haematol.** 2024;204(5):1790–1800.  
PubMed: [38414235](https://pubmed.ncbi.nlm.nih.gov/38414235/) · DOI: [10.1111/bjh.19332](https://doi.org/10.1111/bjh.19332)

---

**SARS-CoV-2 antibody kinetics in unvaccinated hospitalized children with COVID-19**  
Dimopoulou D, Charakida M, Marmarinos A, Karaviti D, **Avgeris M**, Gourgiotis D, Tsolia MN  
**Pediatr Infect Dis J.** 2024;43(6):536–542.  
PubMed: [38372544](https://pubmed.ncbi.nlm.nih.gov/38372544/) · DOI: [10.1097/INF.0000000000004301](https://doi.org/10.1097/INF.0000000000004301)

---

**28S rRNA-derived fragments represent an independent molecular predictor of short-term relapse in prostate cancer**  
Diamantopoulos MA, Georgoulia KK, Levis P, Kotronopoulos G, Stravodimos K, Kontos CK, **Avgeris M**, Scorilas A  
**Int J Mol Sci.** 2023;25(1):239.  
PubMed: [38203408](https://pubmed.ncbi.nlm.nih.gov/38203408/) · DOI: [10.3390/ijms25010239](https://doi.org/10.3390/ijms25010239)

---

**Spike-Seq: An amplicon-based high-throughput sequencing approach for the sensitive detection and characterization of SARS-CoV-2 genetic variations in environmental samples**  
Adamopoulos PG, Diamantopoulos MA, Boti MA, Zafeiriadou A, Galani A, Kostakis M, Markou A, Sideris DC, **Avgeris M**, Thomaidis NS, Scorilas A  
**Sci Total Environ.** 2024;914:169747.  
PubMed: [38159750](https://pubmed.ncbi.nlm.nih.gov/38159750/) · DOI: [10.1016/j.scitotenv.2023.169747](https://doi.org/10.1016/j.scitotenv.2023.169747)

---

**miRNA-based technologies in cancer therapy**  
Pagoni M, Cava C, Sideris DC, **Avgeris M**, Zoumpourlis V, Michalopoulos I, Drakoulis N  
**J Pers Med.** 2023;13(11):1586.  
PubMed: [38003902](https://pubmed.ncbi.nlm.nih.gov/38003902/) · DOI: [10.3390/jpm13111586](https://doi.org/10.3390/jpm13111586)

---

**Cancer quiescence: non-coding RNAs in the spotlight**  
Soureas K, Papadimitriou MA, Panoutsopoulou K, Pilala KM, Scorilas A, **Avgeris M**  
**Trends Mol Med.** 2023;29(10):843–858.  
PubMed: [37516569](https://pubmed.ncbi.nlm.nih.gov/37516569/) · DOI: [10.1016/j.molmed.2023.07.003](https://doi.org/10.1016/j.molmed.2023.07.003)

---

**Association of high miR-27a, miR-206, and miR-214 expression with poor patient prognosis and increased chemoresistance in triple-negative breast cancer**  
Liu Y, Gong W, Panoutsopoulou K, Singer-Cornelius T, Augustin K, Bronger H, Kiechle M, Dorn J, Scorilas A, **Avgeris M**, Magdolen V, Dreyer T  
**Am J Cancer Res.** 2023;13(6):2471–2487.  
PubMed: [37424802](https://pubmed.ncbi.nlm.nih.gov/37424802/)

---

**First trimester maternal plasma proteomic changes predictive of spontaneous moderate/late preterm delivery**  
Mavreli D, Theodora M, Lambrou G, **Avgeris M**, Papantoniou N, Treager-Synodinos J, Daskalakis G, Kolialexi A  
**J Matern Fetal Neonatal Med.** 2023;36(2):2232074.  
PubMed: [37424082](https://pubmed.ncbi.nlm.nih.gov/37424082/) · DOI: [10.1080/14767058.2023.2232074](https://doi.org/10.1080/14767058.2023.2232074)

---

**Deregulated expression of IL-37 in patients with bladder urothelial cancer: The diagnostic potential of the IL-37e isoform**  
Papasavva M, Amvrosiou S, Pilala KM, Soureas K, Christodoulou P, Ji Y, Stravodimos K, Xu D, Scorilas A, **Avgeris M**, Christodoulou MI  
**Int J Mol Sci.** 2023;24(11):9258.  
PubMed: [37298214](https://pubmed.ncbi.nlm.nih.gov/37298214/) · DOI: [10.3390/ijms24119258](https://doi.org/10.3390/ijms24119258)

---

**miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma**  
Papadimitriou MA, Soureas K, Papanota AM, Tsiakanikas P, Adamopoulos PG, Ntanasis-Stathopoulos I, Malandrakis P, Gavriatopoulou M, Sideris DC, Kastritis E, **Avgeris M**, Dimopoulos MA, Terpos E, Scorilas A  
**J Transl Med.** 2023;21(1):245.  
PubMed: [37024879](https://pubmed.ncbi.nlm.nih.gov/37024879/) · DOI: [10.1186/s12967-023-04034-5](https://doi.org/10.1186/s12967-023-04034-5)

---

**Short-term starvation potentiates the efficacy of chemotherapy in triple-negative breast cancer via metabolic reprogramming**  
Pateras IS, Williams C, Gianniou DD, Margetis AT, **Avgeris M**, Rousakis P, Legaki AI, Mirtschink P, Zhang W, Panoutsopoulou K, Delis AD, Pagakis SN, Tang W, Ambs S, Warpman Berglund U, Helleday T, Varvarigou A, Chatzigeorgiou A, Nordström A, Tsitsilonis OE, Trougakos IP, Gilthorpe JD, Frisan T  
**J Transl Med.** 2023;21(1):169.  
PubMed: [36869333](https://pubmed.ncbi.nlm.nih.gov/36869333/) · DOI: [10.1186/s12967-023-03935-9](https://doi.org/10.1186/s12967-023-03935-9)

---

**Evaluation of the small heat shock protein family members HSPB2 and HSPB3 in bladder cancer prognosis and progression**  
Gianniou DD, Sklirou AD, Papadimitriou MA, Pilala KM, Stravodimos K, **Avgeris M**, Scorilas A, Trougakos IP  
**Int J Mol Sci.** 2023;24(3):2609.  
PubMed: [36768927](https://pubmed.ncbi.nlm.nih.gov/36768927/) · DOI: [10.3390/ijms24032609](https://doi.org/10.3390/ijms24032609)

---

**Preoperative cell-free DNA (cfDNA) in muscle-invasive bladder cancer treatment outcome**  
Papadimitriou MA, Levis P, Kotronopoulos G, Stravodimos K, **Avgeris M**, Scorilas A  
**Clin Chem.** 2023;69(4):399–410.  
PubMed: [36738246](https://pubmed.ncbi.nlm.nih.gov/36738246/) · DOI: [10.1093/clinchem/hvac218](https://doi.org/10.1093/clinchem/hvac218)

---

**Advancing desulfurization in the model biocatalyst *Rhodococcus qingshengii* IGTS8 via an in locus combinatorial approach**  
Martzoukou O, Amillis S, Glekas PD, Breyanni D, **Avgeris M**, Scorilas A, Kekos D, Pachnos M, Mavridis G, Mamma D, Hatzinikolaou DG  
**Appl Environ Microbiol.** 2023;89(2):e01970-22.  
PubMed: [36688659](https://pubmed.ncbi.nlm.nih.gov/36688659/) · DOI: [10.1128/aem.01970-22](https://doi.org/10.1128/aem.01970-22)

---

**tRNA-derived small RNA 3′U-tRFValCAC promotes tumour migration and early progression in ovarian cancer**  
Panoutsopoulou K, Magkou P, Dreyer T, Dorn J, Obermayr E, Mahner S, van Gorp T, Braicu I, Magdolen V, Zeillinger R, **Avgeris M**, Scorilas A  
**Eur J Cancer.** 2023;180:134–145.  
PubMed: [36599181](https://pubmed.ncbi.nlm.nih.gov/36599181/) · DOI: [10.1016/j.ejca.2022.11.033](https://doi.org/10.1016/j.ejca.2022.11.033)

---

**Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancer**  
Panoutsopoulou K, Liu Y, **Avgeris M**, Dreyer T, Dorn J, Magdolen V, Scorilas A  
**Clin Biochem.** 2023;114:43–51.  
PubMed: [36502883](https://pubmed.ncbi.nlm.nih.gov/36502883/) · DOI: [10.1016/j.clinbiochem.2022.12.004](https://doi.org/10.1016/j.clinbiochem.2022.12.004)

---

**First trimester maternal plasma aberrant miRNA expression associated with spontaneous preterm birth**  
Mavreli D, Theodora M, **Avgeris M**, Papantoniou N, Antsaklis P, Daskalakis G, Kolialexi A  
**Int J Mol Sci.** 2022;23(23):14972.  
PubMed: [36499299](https://pubmed.ncbi.nlm.nih.gov/36499299/) · DOI: [10.3390/ijms232314972](https://doi.org/10.3390/ijms232314972)

---

**Corrigendum to “Delta SARS-CoV-2 variant is entirely substituted by the omicron variant during the fifth COVID-19 wave in Attica region”**  
Galani A, Markou A, Dimitrakopoulos L, Kontou A, Kostakis M, Kapes V, Diamantopoulos MA, Adamopoulos PG, **Avgeris M**, Lianidou E, Scorilas A, Paraskevis D, Tsiodras S, Dimopoulos MA, Thomaidis N  
**Sci Total Environ.** 2023;860:160544.  
PubMed: [36460542](https://pubmed.ncbi.nlm.nih.gov/36460542/) · DOI: [10.1016/j.scitotenv.2022.160544](https://doi.org/10.1016/j.scitotenv.2022.160544)

---

**Epigenetic regulation of MIR145 core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcome**  
Pilala KM, Papadimitriou MA, Panoutsopoulou K, Barbarigos P, Levis P, Kotronopoulos G, Stravodimos K, Scorilas A, **Avgeris M**  
**Mol Ther Nucleic Acids.** 2022;30:311–322.  
PubMed: [36320325](https://pubmed.ncbi.nlm.nih.gov/36320325/) · DOI: [10.1016/j.omtn.2022.10.001](https://doi.org/10.1016/j.omtn.2022.10.001)

---

**Delta SARS-CoV-2 variant is entirely substituted by the omicron variant during the fifth COVID-19 wave in Attica region**  
Galani A, Markou A, Dimitrakopoulos L, Kontou A, Kostakis M, Kapes V, Diamantopoulos MA, Adamopoulos PG, **Avgeris M**, Lianidou E, Scorilas A, Paraskevis D, Tsiodras S, Dimopoulos MA, Thomaidis N  
**Sci Total Environ.** 2023;856(Pt 1):159062.  
PubMed: [36181801](https://pubmed.ncbi.nlm.nih.gov/36181801/) · DOI: [10.1016/j.scitotenv.2022.159062](https://doi.org/10.1016/j.scitotenv.2022.159062)

---

**Interplay between sulfur assimilation and biodesulfurization activity in *Rhodococcus qingshengii* IGTS8: Insights into a regulatory role of the reverse transsulfuration pathway**  
Martzoukou O, Glekas PD, **Avgeris M**, Mamma D, Scorilas A, Kekos D, Amillis S, Hatzinikolaou DG  
**mBio.** 2022;13(4):e00754-22.  
PubMed: [35856606](https://pubmed.ncbi.nlm.nih.gov/35856606/) · DOI: [10.1128/mbio.00754-22](https://doi.org/10.1128/mbio.00754-22)

---

**Epi-miRNAs: Modern mediators of methylation status in human cancers**  
Papadimitriou MA, Panoutsopoulou K, Pilala KM, Scorilas A, **Avgeris M**  
**Wiley Interdiscip Rev RNA.** 2023;14(2):e1735.  
PubMed: [35580998](https://pubmed.ncbi.nlm.nih.gov/35580998/) · DOI: [10.1002/wrna.1735](https://doi.org/10.1002/wrna.1735)

---

**Inadequate protection against measles and rubella among pregnant women in Greece during the last measles outbreak**  
Papailiou S, Soldatou A, Marmarinos A, **Avgeris M**, Papathoma E, Sindos M, Georgantzi S, Rodolakis A, Iacovidou N, Gourgiotis D, Tsolia M  
**J Infect.** 2022;84(6):e95–e97.  
PubMed: [35398404](https://pubmed.ncbi.nlm.nih.gov/35398404/) · DOI: [10.1016/j.jinf.2022.04.012](https://doi.org/10.1016/j.jinf.2022.04.012)

---

**tRNAGlyGCC-derived internal fragment (i-tRF-GlyGCC) in ovarian cancer treatment outcome and progression**  
Panoutsopoulou K, Dreyer T, Dorn J, Obermayr E, Mahner S, Gorp TV, Braicu I, Zeillinger R, Magdolen V, **Avgeris M**, Scorilas A  
**Cancers (Basel).** 2021;14(1):24.  
PubMed: [35008188](https://pubmed.ncbi.nlm.nih.gov/35008188/) · DOI: [10.3390/cancers14010024](https://doi.org/10.3390/cancers14010024)

---

**Overexpression of the GR riborepressor lncRNA GAS5 results in poor treatment response and early relapse in childhood B-ALL**  
Xagorari M, Marmarinos A, Kossiva L, Baka M, Doganis D, Servitzoglou M, Tsolia M, Scorilas A, **Avgeris M**, Gourgiotis D  
**Cancers (Basel).** 2021;13(23):6064.  
PubMed: [34885174](https://pubmed.ncbi.nlm.nih.gov/34885174/) · DOI: [10.3390/cancers13236064](https://doi.org/10.3390/cancers13236064)

---

**A cancer-related microRNA signature shows biomarker utility in multiple myeloma**  
Papanota AM, Karousi P, Kontos CK, Artemaki PI, Liacos CI, Papadimitriou MA, Bagratuni T, Eleutherakis-Papaiakovou E, Malandrakis P, Ntanasis-Stathopoulos I, Gavriatopoulou M, Kastritis E, **Avgeris M**, Dimopoulos MA, Scorilas A, Terpos E  
**Int J Mol Sci.** 2021;22(23):13144.  
PubMed: [34884950](https://pubmed.ncbi.nlm.nih.gov/34884950/) · DOI: [10.3390/ijms222313144](https://doi.org/10.3390/ijms222313144)

---

**miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome**  
Papadimitriou MA, Papanota AM, Adamopoulos PG, Pilala KM, Liacos CI, Malandrakis P, Mavrianou-Koutsoukou N, Patseas D, Eleutherakis-Papaiakovou E, Gavriatopoulou M, Kastritis E, **Avgeris M**, Dimopoulos MA, Terpos E, Scorilas A  
**Br J Cancer.** 2022;126(1):79–90.  
PubMed: [34718359](https://pubmed.ncbi.nlm.nih.gov/34718359/) · DOI: [10.1038/s41416-021-01602-8](https://doi.org/10.1038/s41416-021-01602-8)

---

**SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissions**  
Galani A, Aalizadeh R, Kostakis M, Markou A, Alygizakis N, Lytras T, Adamopoulos PG, Peccia J, Thompson DC, Kontou A, Karagiannidis A, Lianidou ES, **Avgeris M**, Paraskevis D, Tsiodras S, Scorilas A, Vasiliou V, Dimopoulos MA, Thomaidis NS  
**Sci Total Environ.** 2022;804:150151.  
PubMed: [34623953](https://pubmed.ncbi.nlm.nih.gov/34623953/) · DOI: [10.1016/j.scitotenv.2021.150151](https://doi.org/10.1016/j.scitotenv.2021.150151)

---

**Novel nested-seq approach for SARS-CoV-2 real-time epidemiology and in-depth mutational profiling in wastewater**  
**Avgeris M**, Adamopoulos PG, Galani A, Xagorari M, Gourgiotis D, Trougakos IP, Voulgaris N, Dimopoulos MA, Thomaidis NS, Scorilas A  
**Int J Mol Sci.** 2021;22(16):8498.  
PubMed: [34445204](https://pubmed.ncbi.nlm.nih.gov/34445204/) · DOI: [10.3390/ijms22168498](https://doi.org/10.3390/ijms22168498)

---

**A molecular signature of circulating microRNA can predict osteolytic bone disease in multiple myeloma**  
Papanota AM, Tsiakanikas P, Kontos CK, Malandrakis P, Liacos CI, Ntanasis-Stathopoulos I, Kanellias N, Gavriatopoulou M, Kastritis E, **Avgeris M**, Dimopoulos MA, Scorilas A, Terpos E  
**Cancers (Basel).** 2021;13(15):3877.  
PubMed: [34359778](https://pubmed.ncbi.nlm.nih.gov/34359778/) · DOI: [10.3390/cancers13153877](https://doi.org/10.3390/cancers13153877)

---

**Generation of non-small cell lung cancer patient-derived xenografts to study intratumor heterogeneity**  
Kanaki Z, Voutsina A, Markou A, Pateras IS, Potaris K, **Avgeris M**, Makrythanasis P, Athanasiadis EI, Vamvakaris I, Patsea E, Vachlas K, Lianidou E, Georgoulias V, Kotsakis A, Klinakis A  
**Cancers (Basel).** 2021;13(10):2446.  
PubMed: [34070013](https://pubmed.ncbi.nlm.nih.gov/34070013/) · DOI: [10.3390/cancers13102446](https://doi.org/10.3390/cancers13102446)

---

**Clinical activity of an hTERT-specific cancer vaccine (Vx-001) in “immune desert” NSCLC**  
Pateras IS, Kotsakis A, **Avgeris M**, Baliou E, Kouroupakis P, Patsea E, Georgoulias V, Menez-Jamet J, Kinet JP, Kosmatopoulos K  
**Cancers (Basel).** 2021;13(7):1658.  
PubMed: [33916194](https://pubmed.ncbi.nlm.nih.gov/33916194/) · DOI: [10.3390/cancers13071658](https://doi.org/10.3390/cancers13071658)

---

**Jagged ends of cell-free DNA: Rebranding fragmentomics in modern liquid biopsy diagnostics**  
**Avgeris M**, Marmarinos A, Gourgiotis D, Scorilas A  
**Clin Chem.** 2021;67(4):576–578.  
PubMed: [33693633](https://pubmed.ncbi.nlm.nih.gov/33693633/) · DOI: [10.1093/clinchem/hvab036](https://doi.org/10.1093/clinchem/hvab036)

---

**Impact of three-dimensional vision in laparoscopic partial nephrectomy for renal tumors**  
Tokas T, **Avgeris M**, Leotsakos I, Nagele U, Gözen AS  
**Turk J Urol.** 2021;47(2):144–150.  
PubMed: [33337319](https://pubmed.ncbi.nlm.nih.gov/33337319/) · DOI: [10.5152/tud.2020.20439](https://doi.org/10.5152/tud.2020.20439)

---

**tRNA-derived fragments (tRFs) in bladder cancer: Increased 5′-tRF-LysCTT results in disease early progression and patients' poor treatment outcome**  
Papadimitriou MA, **Avgeris M**, Levis P, Papasotiriou EC, Kotronopoulos G, Stravodimos K, Scorilas A  
**Cancers (Basel).** 2020;12(12):3661.  
PubMed: [33291319](https://pubmed.ncbi.nlm.nih.gov/33291319/) · DOI: [10.3390/cancers12123661](https://doi.org/10.3390/cancers12123661)

---

**Analytical methodologies for the detection of SARS-CoV-2 in wastewater: Protocols and future perspectives**  
Alygizakis N, Markou AN, Rousis NI, Galani A, **Avgeris M**, Adamopoulos PG, Scorilas A, Lianidou ES, Paraskevis D, Tsiodras S, Tsakris A, Dimopoulos MA, Thomaidis NS  
**Trends Analyt Chem.** 2021;134:116125.  
PubMed: [33235400](https://pubmed.ncbi.nlm.nih.gov/33235400/) · DOI: [10.1016/j.trac.2020.116125](https://doi.org/10.1016/j.trac.2020.116125)

---

**miR-181a overexpression predicts the poor treatment response and early progression of serous ovarian cancer patients**  
Panoutsopoulou K, **Avgeris M**, Magkou P, Mavridis K, Dreyer T, Dorn J, Obermayr E, Reinthaller A, Michaelidou K, Mahner S, Vergote I, Loverix L, Braicu I, Sehouli J, Zeillinger R, Magdolen V, Scorilas A  
**Int J Cancer.** 2020;147(12):3560–3573.  
PubMed: [32621752](https://pubmed.ncbi.nlm.nih.gov/32621752/) · DOI: [10.1002/ijc.33182](https://doi.org/10.1002/ijc.33182)

---

**Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome**  
**Avgeris M**, Kokkinopoulou I, Maratou E, Mitrou P, Boutati E, Scorilas A, Fragoulis EG, Christodoulou MI  
**Diabetes Res Clin Pract.** 2020;164:108187.  
PubMed: [32360711](https://pubmed.ncbi.nlm.nih.gov/32360711/) · DOI: [10.1016/j.diabres.2020.108187](https://doi.org/10.1016/j.diabres.2020.108187)

---

**Circulating miR-146a and miR-134 in predicting drug-resistant epilepsy in patients with focal impaired awareness seizures**  
Leontariti M, **Avgeris M**, Katsarou MS, Drakoulis N, Siatouni A, Verentzioti A, Alexoudi A, Fytraki A, Patrikelis P, Vassilacopoulou D, Gatzonis S, Sideris DC  
**Epilepsia.** 2020;61(5):959–970.  
PubMed: [32314378](https://pubmed.ncbi.nlm.nih.gov/32314378/) · DOI: [10.1111/epi.16502](https://doi.org/10.1111/epi.16502)

---

**Seafood mislabeling in Greek markets using DNA barcoding analyses**  
Minoudi S, Karaiskou N, **Avgeris M**, Gkagkavouzis K, Tarantili P, Triantafyllidou D, Palilis L, Avramopoulou V, Tsikliras A, Barmperis K, Triantafyllidis A  
**Food Control.** 2020;113:107213.  
DOI: [10.1016/j.foodcont.2020.107213](https://doi.org/10.1016/j.foodcont.2020.107213)

---

**ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression**  
Papadimitriou MA, **Avgeris M**, Levis PK, Tokas T, Stravodimos K, Scorilas A  
**J Cancer Res Clin Oncol.** 2019;145(12):3075–3087.  
PubMed: [31595333](https://pubmed.ncbi.nlm.nih.gov/31595333/) · DOI: [10.1007/s00432-019-03028-5](https://doi.org/10.1007/s00432-019-03028-5)

---

**Circulating exosomal miRNAs: clinical significance in human cancers**  
**Avgeris M**, Panoutsopoulou K, Papadimitriou MA, Scorilas A  
**Expert Rev Mol Diagn.** 2019;19(11):979–995.  
PubMed: [31594418](https://pubmed.ncbi.nlm.nih.gov/31594418/) · DOI: [10.1080/14737159.2019.1673732](https://doi.org/10.1080/14737159.2019.1673732)

---

**miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study**  
Panoutsopoulou K, **Avgeris M**, Mavridis K, Dreyer T, Dorn J, Obermayr E, Reinthaller A, Michaelidou K, Mahner S, Vergote I, Vanderstichele A, Braicu I, Sehouli J, Zeillinger R, Magdolen V, Scorilas A  
**Carcinogenesis.** 2020;41(4):442–451.  
PubMed: [31586203](https://pubmed.ncbi.nlm.nih.gov/31586203/) · DOI: [10.1093/carcin/bgz163](https://doi.org/10.1093/carcin/bgz163)

---

**HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: a pilot study**  
Economopoulou P, Koutsodontis G, **Avgeris M**, Strati A, Kroupis C, Pateras I, Kirodimos E, Giotakis E, Kotsantis I, Maragoudakis P, Gorgoulis V, Scorilas A, Lianidou E, Psyrri A  
**PLoS One.** 2019;14(5):e0215984.  
PubMed: [31071126](https://pubmed.ncbi.nlm.nih.gov/31071126/) · DOI: [10.1371/journal.pone.0215984](https://doi.org/10.1371/journal.pone.0215984)

---

**Revisiting histone deacetylases in human tumorigenesis: the paradigm of urothelial bladder cancer**  
Giannopoulou AF, Velentzas AD, Konstantakou EG, **Avgeris M**, Katarachia SA, Papandreou NC, Kalavros NI, Mpakou VE, Iconomidou V, Anastasiadou E, Kostakis IK, Papassideri IS, Voutsinas GE, Scorilas A, Stravopodis DJ  
**Int J Mol Sci.** 2019;20(6):1291.  
PubMed: [30875794](https://pubmed.ncbi.nlm.nih.gov/30875794/) · DOI: [10.3390/ijms20061291](https://doi.org/10.3390/ijms20061291)

---

**Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer**  
**Avgeris M**, Tsilimantou A, Levis PK, Rampias T, Papadimitriou MA, Panoutsopoulou K, Stravodimos K, Scorilas A  
**Carcinogenesis.** 2019;40(8):965–974.  
PubMed: [30815670](https://pubmed.ncbi.nlm.nih.gov/30815670/) · DOI: [10.1093/carcin/bgz045](https://doi.org/10.1093/carcin/bgz045)

---

**Gene-specific intron retention serves as molecular signature that distinguishes melanoma from non-melanoma cancer cells in Greek patients**  
Giannopoulou AF, Konstantakou EG, Velentzas AD, Avgeris SN, **Avgeris M**, Papandreou NC, Zoi I, Filippa V, Katarachia S, Lampidonis AD, Prombona A, Syntichaki P, Piperi C, Basdra EK, Iconomidou V, Papadavid E, Anastasiadou E, Papassideri IS, Papavassiliou AG, Voutsinas GE, Scorilas A, Stravopodis DJ  
**Int J Mol Sci.** 2019;20(4):937.  
PubMed: [30795533](https://pubmed.ncbi.nlm.nih.gov/30795533/) · DOI: [10.3390/ijms20040937](https://doi.org/10.3390/ijms20040937)

---

**Blood-based analysis of type-2 diabetes mellitus susceptibility genes identifies specific transcript variants with deregulated expression and association with disease risk**  
Christodoulou MI, **Avgeris M**, Kokkinopoulou I, Maratou E, Mitrou P, Kontos CK, Pappas E, Boutati E, Scorilas A, Fragoulis EG  
**Sci Rep.** 2019;9(1):1512.  
PubMed: [30728419](https://pubmed.ncbi.nlm.nih.gov/30728419/) · DOI: [10.1038/s41598-018-37856-1](https://doi.org/10.1038/s41598-018-37856-1)

---

**The lysine-specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer**  
Rampias T, Karagiannis D, **Avgeris M**, Polyzos A, Kokkalis A, Kanaki Z, Kousidou E, Tzetis M, Kanavakis E, Stravodimos K, Manola KN, Pantelias GE, Scorilas A, Klinakis A  
**EMBO Rep.** 2019;20(3):e46821.  
PubMed: [30665945](https://pubmed.ncbi.nlm.nih.gov/30665945/) · DOI: [10.15252/embr.201846821](https://doi.org/10.15252/embr.201846821)

---

**Molecular effects of treatment of human colorectal cancer cells with natural and classical chemotherapeutic drugs: alterations in the expression of apoptosis-related BCL2 family members, including BCL2L12**  
Kontos CK, **Avgeris M**, Vassilacopoulou D, Ardavanis A, Scorilas A  
**Curr Pharm Biotechnol.** 2018;19(13):1064–1075.  
PubMed: [30417787](https://pubmed.ncbi.nlm.nih.gov/30417787/) · DOI: [10.2174/1389201019666181112101410](https://doi.org/10.2174/1389201019666181112101410)

---

**Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients**  
**Avgeris M**, Tsilimantou A, Levis PK, Tokas T, Sideris DC, Stravodimos K, Ardavanis A, Scorilas A  
**Br J Cancer.** 2018;119(12):1477–1486.  
PubMed: [30374124](https://pubmed.ncbi.nlm.nih.gov/30374124/) · DOI: [10.1038/s41416-018-0320-6](https://doi.org/10.1038/s41416-018-0320-6)

---

**miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers**  
Panoutsopoulou K, **Avgeris M**, Scorilas A  
**Expert Rev Mol Diagn.** 2018;18(11):963–979.  
PubMed: [30338716](https://pubmed.ncbi.nlm.nih.gov/30338716/) · DOI: [10.1080/14737159.2018.1538794](https://doi.org/10.1080/14737159.2018.1538794)

---

**BCL2L12 improves risk stratification and prediction of BFM-chemotherapy response in childhood acute lymphoblastic leukemia**  
**Avgeris M**, Stamati L, Kontos CK, Piatopoulou D, Marmarinos A, Xagorari M, Baka M, Doganis D, Anastasiou T, Kosmidis H, Gourgiotis D, Scorilas A  
**Clin Chem Lab Med.** 2018;56(12):2104–2118.  
PubMed: [30016275](https://pubmed.ncbi.nlm.nih.gov/30016275/) · DOI: [10.1515/cclm-2018-0507](https://doi.org/10.1515/cclm-2018-0507)

---

**Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia**  
Piatopoulou D, **Avgeris M**, Drakaki I, Marmarinos A, Xagorari M, Baka M, Pourtsidis A, Kossiva L, Gourgiotis D, Scorilas A  
**Ann Hematol.** 2018;97(7):1169–1182.  
PubMed: [29556721](https://pubmed.ncbi.nlm.nih.gov/29556721/) · DOI: [10.1007/s00277-018-3292-y](https://doi.org/10.1007/s00277-018-3292-y)

---

**miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression**  
Tsikrika FD, **Avgeris M**, Levis PK, Tokas T, Stravodimos K, Scorilas A  
**Genes Chromosomes Cancer.** 2018;57(3):150–161.  
PubMed: [29181884](https://pubmed.ncbi.nlm.nih.gov/29181884/) · DOI: [10.1002/gcc.22516](https://doi.org/10.1002/gcc.22516)

---

**Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma**  
Strati A, Koutsodontis G, Papaxoinis G, Angelidis I, Zavridou M, Economopoulou P, Kotsantis I, **Avgeris M**, Mazel M, Perisanidis C, Sasaki C, Alix-Panabières C, Lianidou E, Psyrri A  
**Ann Oncol.** 2017;28(8):1923–1933.  
PubMed: [28838214](https://pubmed.ncbi.nlm.nih.gov/28838214/) · DOI: [10.1093/annonc/mdx206](https://doi.org/10.1093/annonc/mdx206)

---

**miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment**  
Piatopoulou D, **Avgeris M**, Marmarinos A, Xagorari M, Baka M, Doganis D, Kossiva L, Scorilas A, Gourgiotis D  
**Br J Cancer.** 2017;117(6):801–812.  
PubMed: [28787435](https://pubmed.ncbi.nlm.nih.gov/28787435/) · DOI: [10.1038/bjc.2017.256](https://doi.org/10.1038/bjc.2017.256)

---

**Combining the ETHOS operating ergonomic platform, three-dimensional laparoscopic camera, and Radius surgical system manipulators improves ergonomics in urologic laparoscopy: comparison with conventional laparoscopy and da Vinci in a pelvic trainer**  
Tokas T, Gözen AS, **Avgeris M**, Tschada A, Fiedler M, Klein J, Rassweiler J  
**Eur Urol Focus.** 2017;3(4–5):413–420.  
PubMed: [28753821](https://pubmed.ncbi.nlm.nih.gov/28753821/) · DOI: [10.1016/j.euf.2016.11.006](https://doi.org/10.1016/j.euf.2016.11.006)

---

**Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma receiving cisplatin and 5-fluorouracil with or without docetaxel: a subset analysis of the EORTC 24971 study** *(Clinical Trial)*  
Psyrri A, Fortpied C, Koutsodontis G, **Avgeris M**, Kroupis C, Goutas N, Menis J, Herman L, Giurgea L, Remenár É, Degardin M, Pateras IS, Langendijk JA, van Herpen CML, Awada A, Germà-Lluch JR, Kienzer HR, Licitra L, Vermorken JB  
**Ann Oncol.** 2017;28(9):2213–2218.  
PubMed: [28651338](https://pubmed.ncbi.nlm.nih.gov/28651338/) · DOI: [10.1093/annonc/mdx320](https://doi.org/10.1093/annonc/mdx320)

---

**miR-15a-5p, a novel prognostic biomarker predicting recurrent colorectal adenocarcinoma**  
Kontos CK, Tsiakanikas P, **Avgeris M**, Papadopoulos IN, Scorilas A  
**Mol Diagn Ther.** 2017;21(4):453–464.  
PubMed: [28405803](https://pubmed.ncbi.nlm.nih.gov/28405803/) · DOI: [10.1007/s40291-017-0270-3](https://doi.org/10.1007/s40291-017-0270-3)

---

**Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients’ prognosis**  
Tokas T, **Avgeris M**, Alamanis C, Scorilas A, Stravodimos KG, Constantinides CA  
**J Cancer Res Clin Oncol.** 2017;143(3):521–532.  
PubMed: [27858162](https://pubmed.ncbi.nlm.nih.gov/27858162/) · DOI: [10.1007/s00432-016-2301-6](https://doi.org/10.1007/s00432-016-2301-6)

---

**Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies**  
**Avgeris M**, Scorilas A  
**Expert Opin Ther Targets.** 2016;20(7):801–818.  
PubMed: [26941073](https://pubmed.ncbi.nlm.nih.gov/26941073/) · DOI: [10.1517/14728222.2016.1147560](https://doi.org/10.1517/14728222.2016.1147560)

---

**Evaluation of PD-L1 expression and associated tumor-infiltrating lymphocytes in laryngeal squamous cell carcinoma**  
Vassilakopoulou M, **Avgeris M**, Velcheti V, Kotoula V, Rampias T, Chatzopoulos K, Perisanidis C, Kontos CK, Giotakis AI, Scorilas A, Rimm D, Sasaki C, Fountzilas G, Psyrri A  
**Clin Cancer Res.** 2016;22(3):704–713.  
PubMed: [26408403](https://pubmed.ncbi.nlm.nih.gov/26408403/) · DOI: [10.1158/1078-0432.CCR-15-1543](https://doi.org/10.1158/1078-0432.CCR-15-1543)

---

**Overexpression of BCL2 and BAX following BFM induction therapy predicts childhood acute lymphoblastic leukemia patients’ poor response to treatment and short-term relapse**  
Stamati L, **Avgeris M**, Kosmidis H, Baka M, Anastasiou T, Piatopoulou D, Scorilas A, Gourgiotis D  
**J Cancer Res Clin Oncol.** 2015;141(11):2023–2036.  
PubMed: [25982455](https://pubmed.ncbi.nlm.nih.gov/25982455/) · DOI: [10.1007/s00432-015-1982-6](https://doi.org/10.1007/s00432-015-1982-6)

---

**Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment**  
**Avgeris M**, Mavridis K, Tokas T, Stravodimos K, Fragoulis EG, Scorilas A  
**Carcinogenesis.** 2015;36(5):528–537.  
PubMed: [25804644](https://pubmed.ncbi.nlm.nih.gov/25804644/) · DOI: [10.1093/carcin/bgv024](https://doi.org/10.1093/carcin/bgv024)

---

**A new tumor suppressor role for the Notch pathway in bladder cancer**  
Rampias T, Vgenopoulou P, **Avgeris M**, Polyzos A, Stravodimos K, Valavanis C, Scorilas A, Klinakis A  
**Nat Med.** 2014;20(10):1199–1205.  
PubMed: [25194568](https://pubmed.ncbi.nlm.nih.gov/25194568/) · DOI: [10.1038/nm.3678](https://doi.org/10.1038/nm.3678)

---

**Loss of miR-378 in prostate cancer, a common regulator of KLK2 and KLK4, correlates with aggressive disease phenotype and predicts short-term relapse**  
**Avgeris M**, Stravodimos K, Scorilas A  
**Biol Chem.** 2014;395(9):1095–1104.  
PubMed: [25153390](https://pubmed.ncbi.nlm.nih.gov/25153390/) · DOI: [10.1515/hsz-2014-0150](https://doi.org/10.1515/hsz-2014-0150)

---

**Targeting kallikrein-related peptidases in prostate cancer**  
Mavridis K, **Avgeris M**, Scorilas A  
**Expert Opin Ther Targets.** 2014;18(4):365–383.  
PubMed: [24571737](https://pubmed.ncbi.nlm.nih.gov/24571737/) · DOI: [10.1517/14728222.2014.880693](https://doi.org/10.1517/14728222.2014.880693)

---

**Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors**  
Foutadakis S, **Avgeris M**, Tokas T, Stravodimos K, Scorilas A  
**Urol Oncol.** 2014;32(1):39.e29–39.e36.  
PubMed: [23790536](https://pubmed.ncbi.nlm.nih.gov/23790536/) · DOI: [10.1016/j.urolonc.2013.04.005](https://doi.org/10.1016/j.urolonc.2013.04.005)

---

**The loss of the tumour-suppressor miR-145 results in shorter disease-free survival of prostate cancer patients**  
**Avgeris M**, Stravodimos K, Fragoulis EG, Scorilas A  
**Br J Cancer.** 2013;108(12):2573–2581.  
PubMed: [23703249](https://pubmed.ncbi.nlm.nih.gov/23703249/) · DOI: [10.1038/bjc.2013.250](https://doi.org/10.1038/bjc.2013.250)

---

**L-dopa decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer**  
Koutalellis G, Stravodimos K, **Avgeris M**, Mavridis K, Scorilas A, Lazaris A, Constantinides C  
**BJU Int.** 2012;110(6 Pt B):E267–E273.  
PubMed: [22571720](https://pubmed.ncbi.nlm.nih.gov/22571720/) · DOI: [10.1111/j.1464-410X.2012.11152.x](https://doi.org/10.1111/j.1464-410X.2012.11152.x)

---

**Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance**  
**Avgeris M**, Mavridis K, Scorilas A  
**Biol Chem.** 2012;393(5):301–317.  
PubMed: [22505514](https://pubmed.ncbi.nlm.nih.gov/22505514/) · DOI: [10.1515/hsz-2011-0260](https://doi.org/10.1515/hsz-2011-0260)

---

**Down-regulation of kallikrein-related peptidase 5 (KLK5) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesions**  
**Avgeris M**, Papachristopoulou G, Polychronis A, Scorilas A  
**Clin Proteomics.** 2011;8(1):5.  
PubMed: [21906360](https://pubmed.ncbi.nlm.nih.gov/21906360/) · DOI: [10.1186/1559-0275-8-5](https://doi.org/10.1186/1559-0275-8-5)

---

**Kallikrein-related peptidase 4 gene (KLK4) in prostate tumors: quantitative expression analysis and evaluation of its clinical significance**  
**Avgeris M**, Stravodimos K, Scorilas A  
**Prostate.** 2011;71(16):1780–1789.  
PubMed: [21520157](https://pubmed.ncbi.nlm.nih.gov/21520157/) · DOI: [10.1002/pros.21395](https://doi.org/10.1002/pros.21395)

---

**Quantitative expression analysis and study of the novel human kallikrein-related peptidase 14 gene (KLK14) in malignant and benign breast tissues**  
Papachristopoulou G, **Avgeris M**, Charlaftis A, Scorilas A  
**Thromb Haemost.** 2011;105(1):131–137.  
PubMed: [21057706](https://pubmed.ncbi.nlm.nih.gov/21057706/) · DOI: [10.1160/TH10-02-0092](https://doi.org/10.1160/TH10-02-0092)

---

**Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies**  
**Avgeris M**, Mavridis K, Scorilas A  
**Biol Chem.** 2010;391(5):505–511.  
PubMed: [20302518](https://pubmed.ncbi.nlm.nih.gov/20302518/) · DOI: [10.1515/BC.2010.056](https://doi.org/10.1515/BC.2010.056)

---

**Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasia**  
Mavridis K, **Avgeris M**, Koutalellis G, Stravodimos K, Scorilas A  
**Cancer Sci.** 2010;101(3):693–699.  
PubMed: [20067463](https://pubmed.ncbi.nlm.nih.gov/20067463/) · DOI: [10.1111/j.1349-7006.2009.01450.x](https://doi.org/10.1111/j.1349-7006.2009.01450.x)

---

**Expression analysis and study of KLK4 in benign and malignant breast tumours**  
Papachristopoulou G, **Avgeris M**, Scorilas A  
**Thromb Haemost.** 2009;101(2):381–387.  
PubMed: [19190825](https://pubmed.ncbi.nlm.nih.gov/19190825/)

---

**Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer**  
**Avgeris M**, Koutalellis G, Fragoulis EG, Scorilas A  
**Clin Biochem.** 2008;41(14–15):1140–1149.  
PubMed: [18586020](https://pubmed.ncbi.nlm.nih.gov/18586020/) · DOI: [10.1016/j.clinbiochem.2008.04.026](https://doi.org/10.1016/j.clinbiochem.2008.04.026)
